Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,201.8
17.0 (0.53%)

 

  • STI Straits Times Index
    3,201.8
    17.0 (0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,608.4
    0.1 (0.01%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,969.7
    176.6 (0.61%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,426.6
    27.6 (0.81%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,683.4
    40.7 (0.14%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,086.3
    6.8 (0.11%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,374.9M
  • Value: 1,252.7M
  • Rise: 197
  • Fall: 122
  • Unch: 451

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MM2 Asia0.060+0.003
Singtel2.550+0.120
Sembcorp Marine0.205+0.006
Oceanus^0.041+0.002
Blumont0.005+0.001
Jiutian Chemical0.099-
Thomson Medical0.112-0.001
Edition0.009+0.001
Genting Sing0.900-
ThaiBev0.745-0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,052.3 +13.6
HSI 28,969.7 +176.6
HSCEI 11,027.5 +121.6
Jakarta 6,086.3 +6.8
Nikkei 225 29,683.4 +40.7
SSE Comp 3,426.6 +27.6
Shanghai A 3,591.6 +29.0
Shanghai B 247.6 +1.6
KOSPI 3,198.6 +4.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

ALKERMES PLC ALKERMES PLC
Updated on 16 Apr 2021 (End of trading day)
Last (USD): 19.870 Change: +0.100 High: 19.995 Remarks: -
Change (%): +0.51 Low: 19.570
Open 19.950 Yesterday's Close 19.77
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,318,699 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.69620 Trailing EPS (USD) e -0.69620 NAV (USD) b 6.7005
PE a - Trailing PE f - Price / NAV b 2.9655
Dividend (USD) d - Cash In Hand (USD) g 1.7142 Issued & Paid-up Shares c 159,238,000
Dividend Yield (%) d - Price / Cash In Hand g 11.591 Treasury Shares h 3,108,079
Market Cap (M) 3,164.059 Enterprise Value (M) 2,939.189
Piotroski F Score 3 Exchange Code ALKS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 42.61 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Feb 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALKERMES PLC NASDAQ 3,164.059 - - 2.9655 -
Industry Biotechnology NASDAQ 2,961.412 106.306 106.381 6.8608 0.597
Local Peer AMGEN INC NASDAQ 147,238.329 20.270 20.270 15.6487 2.514
Local Peer GILEAD SCIENCES INC NASDAQ 84,028.842 683.183 683.161 4.6165 4.059
Local Peer MODERNA INC NASDAQ 68,354.746 - - 26.6866 -
Local Peer ILLUMINA INC NASDAQ 58,214.100 88.741 88.741 12.4018 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,782.739 20.940 20.940 6.5367 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 53,844.528 15.326 15.326 4.8837 -
Local Peer BIOGEN INC NASDAQ 40,696.522 10.173 10.173 3.8033 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 36,160.349 59.928 59.928 3.1036 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 36,600.092 2,112.645 2,112.519 21.8049 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 28,018.385 - - 7.2413 -
Local Peer SEAGEN INC NASDAQ 26,380.023 42.987 42.987 7.5629 -
Local Peer EXACT SCIENCES CORP NASDAQ 21,988.854 - - 7.7879 -
Other Local Peers 10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), INSMED INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), SEER INC (NASDAQ), ARVINAS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), INSTIL BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MACROGENICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CYTOKINETICS INC (NASDAQ), FIBROGEN INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BIOATLA INC (NASDAQ), UNIQURE N.V. (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), IMMUNOGEN INC (NASDAQ), REGENXBIO INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ALLOVIR INC (NASDAQ), ALECTOR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), CORTEXYME INC (NASDAQ), OMEROS CORP (NASDAQ), PROTHENA CORP PLC (NASDAQ), CURIS INC (NASDAQ), AFFIMED N V (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HUMANIGEN INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), INHIBRX INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CHIMERIX INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KADMON HLDGS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AGENUS INC (NASDAQ), AKOUOS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), AVROBIO INC (NASDAQ), ALTIMMUNE INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ATRECA INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ADICET BIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CUE BIOPHARMA INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), SESEN BIO INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), ONCORUS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), IMMUNOME INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NEXTCURE INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), SAVARA INC (NASDAQ), BIOVIE INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), EVOGENE LTD (NASDAQ), CHIASMA INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), LONGEVERON INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), OTONOMY INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), METACRINE INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), INFLARX N V (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), BIOCARDIA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), HISTOGEN INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PRECIPIO INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), GEOVAX LABS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 122,459.138 39.046 32.177 11.5885 1.090
Global Peer WUXI BIO HKEx 438,060.537 230.825 230.827 17.9665 -
Global Peer BEIGENE HKEx 220,899.836 - - 7.3630 -
Global Peer SINO BIOPHARM HKEx 151,639.494 48.698 48.698 7.6369 -
Global Peer ZAI LAB-SB HKEx 110,558.395 - - 12.1936 -
Global Peer JOINN HKEx 36,317.042 102.597 102.597 25.0065 0.246
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,159.711 13.634 13.634 2.8747 -
Global Peer GENSCRIPT BIO HKEx 29,691.415 - - 4.2466 -
Global Peer NUVATION BIO INC NYSE 2,470.327 - - 17.3707 -
Other Global Peers ARCUS BIOSCIENCES INC (NYSE), 3SBIO (HKEx), KINTOR PHARMA-B (HKEx), JACOBIO-B (HKEx), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), JW THERAP-B (HKEx), POLYNOVO LIMITED (ASX), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), JHBP-B (HKEx), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), ANTEOTECH LIMITED (ASX), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), SQZ BIOTECHNOLOGIES CO (NYSE), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), ENZO BIOCHEM INC (NYSE), BIOMX INC (NYSE American), CEL-SCI CORP (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), NEUREN PHARMACEUTICALS LTD (ASX), IBIO INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), LEAF RESOURCES LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), UNI-BIO GROUP (HKEx), ACTINOGEN MEDICAL LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City (SGX), ADALTA LTD (ASX), BIOSINO BIO-TEC (HKEx), REGENEUS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CRYOSITE (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.850
+4.47 %
10 Days -+0.720
+3.76 %
20 Days --0.180
-0.90 %
Medium Term Return 3 Months --2.500
-11.18 %
6 Months -+2.740
+16.00 %
1 Year -+3.510
+21.45 %
Long Term Return 2 Years --13.710
-40.83 %
3 Years --26.150
-56.82 %
5 Years --22.800
-53.43 %
Annualised Return Annualised --
-14.17 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 13.030 - 23.920 Change From 1 Year Low +6.840 % Change From 1 Year Low (%) +52.49
Change From 1 Year High -4.050 % Change From 1 Year High (%) -16.93
2 Years Range 11.980 - 34.970 Change From 2 Years Low +7.890 % Change From 2 Years Low (%) +65.86
Change From 2 Years High -15.100 % Change From 2 Years High (%) -43.18
5 Years Range 11.980 - 71.220 Change From 5 Years Low +7.890 % Change From 5 Years Low (%) +65.86
Change From 5 Years High -51.350 % Change From 5 Years High (%) -72.10
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Alkermes Plc is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include Aristada, which is used for the treatment of schizophrenia in adults; and Vivitrol, which is an injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Historical Price Data

Date Open High Low Close Volume VWAP
16 Apr 2021 19.950 19.995 19.570 19.870 1,318,699 -
15 Apr 2021 19.320 19.920 19.320 19.770 1,184,162 -
14 Apr 2021 18.850 19.860 18.850 19.230 1,668,712 -
13 Apr 2021 18.790 18.930 18.460 18.860 665,752 -
12 Apr 2021 18.970 18.980 18.430 18.780 1,154,508 -
09 Apr 2021 19.040 19.335 18.840 19.020 1,249,796 -
08 Apr 2021 19.080 19.260 18.850 19.050 1,240,380 -
07 Apr 2021 19.220 19.220 18.920 19.070 746,978 -
06 Apr 2021 19.130 19.690 19.050 19.110 562,962 -
05 Apr 2021 19.140 19.400 18.960 19.260 673,778 -
01 Apr 2021 18.810 19.320 18.490 19.150 802,277 -
31 Mar 2021 18.730 19.235 18.640 18.680 1,249,830 -
30 Mar 2021 19.040 19.345 18.670 18.720 612,895 -
29 Mar 2021 19.330 19.470 18.900 19.065 858,348 -
26 Mar 2021 19.940 19.998 19.150 19.520 769,267 -
25 Mar 2021 19.240 20.090 19.060 19.800 1,202,463 -
24 Mar 2021 19.390 19.770 18.810 19.425 1,399,375 -
23 Mar 2021 20.100 20.280 19.360 19.380 824,309 -
22 Mar 2021 20.120 20.501 20.050 20.270 1,002,686 -
19 Mar 2021 19.760 20.100 19.550 20.050 2,007,484 -
18 Mar 2021 19.970 20.195 19.595 19.620 874,487 -
17 Mar 2021 19.620 20.310 19.450 20.160 1,501,671 -
Summary
Current 2 Weeks
(05 Apr 2021 to 16 Apr 2021)		 19.140 19.995 18.430 19.870 10,465,727 -
Previous 2 Weeks
(19 Mar 2021 to 01 Apr 2021)		 19.760 20.100 18.430 19.150 10,728,934 -
4 Weeks from
(19 Feb 2021 to 18 Mar 2021)		 19.700 20.120 18.430 19.620 23,342,135 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.